TXMD – therapeuticsmd, inc. (US:NASDAQ)
Stock Stats
News
TherapeuticsMD, Inc. (NASDAQ: TXMD) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
TherapeuticsMD Third Quarter 2024 Earnings: US$0.049 loss per share (vs US$0.13 loss in 3Q 2023) [Yahoo! Finance]
TherapeuticsMD, Inc. (NASDAQ: TXMD) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
TherapeuticsMD Announces Third Quarter 2024 Financial Results
TherapeuticsMD, Inc. (NASDAQ: TXMD) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Form SC 13G TherapeuticsMD, Inc. Filed by: Clearline Capital LP
Form 10-Q TherapeuticsMD, Inc. For: Sep 30
Form 8-K TherapeuticsMD, Inc. For: Nov 12
Form ARS TherapeuticsMD, Inc. For: Dec 31
Form DEFA14A TherapeuticsMD, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.